Status:
COMPLETED
High-intensity Inspiratory Muscle Training as a Pre-cardiac Rehabilitation in Heart Disease
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
The Scientific and Technological Research Council of Turkey
Conditions:
Coronary Artery Bypass Graft
CABG
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background/aim: Endothelial function is closely associated with coronary artery health among individuals being treated for heart disease. An impairment in endothelial function promotes arterial stiffe...
Detailed Description
Background: Cardiovascular diseases (CVD) remain a leading cause of morbidity and mortality in both men and women in developed and developing societies (Joseph et al., 2017). Some degree of pulmonary ...
Eligibility Criteria
Inclusion
- Aged \>18 years old
- Be able to walk independently.
- Had coronary artery bypass graft (CABG) surgery, history of percutaneous coronary interventions, heart failure, and/or myocardial infarction.
- Sufficient English language comprehension and cognitive ability to understand the study protocol, give informed consent and follow instructions.
Exclusion
- Being a current smoker (or tobacco).
- Having a diagnosed chronic disease such as inflammatory bowel disease/irritable bowel syndrome, cerebrovascular diseases, COPD, chronic kidney disease requiring dialysis, neurological disorders, or diseases that may affect motor/cognitive function \[multiple sclerosis, Parkinson's disease, polio, Alzheimer's disease, dementia, or other brain diseases of ageing\])
- Getting a score below 24 on the Standardized Mini Mental Test
- Using antipsychotic medications commonly used to treat schizophrenia or schizoaffective disorders (i.e., haloperidol)
- Having had any other previous cardiothoracic operation except CABG (e.g. Pneumonectomy, lobectomy, etc.)
- Having a history of unstable-angina
- Having had pneumonia in the last 3 months
Key Trial Info
Start Date :
December 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06127147
Start Date
December 20 2023
End Date
June 15 2024
Last Update
November 21 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60608
2
University of Illinois Chicago
Chicago, Illinois, United States, 60612